Apparel, Accessories and Luxury Goods

ZHIDA TECH

E-Life Holdings Reports Second Half-Yearly Profit Turnaround

Yi Shenghuo Holding Expected to Turn Profitable for Half-Year

ES Life Holdings Announces Mid-Year Results: Revenue Up, Loss Widened

EasyLife Holdings Sees Annual Loss Widening to 98 Million HKD

Yisheng Life Holdings Board Suspends Five Directors' Positions

Easy Life Holdings Receives Request from Major Shareholder to Investigate Legality of Minority Shareholders' Stock Purchases

Easy Life Holdings Expects Significant Revenue Increase but Increased Losses in H1 2024

Easy Life Holdings Proposes Rights Issue to Raise Up to HKD 27.12 Million by Issuing Up to 271 Million Shares

Easy Life Holdings Establishes Independent Board Committee to Provide Opinions on Partial Acquisition Offer

Acquisition Offer by Easy Life Holdings

China Innovation Investment requests the removal of directors of Easy Life Holdings and appointment of new directors

Yi Shenghuo Holdings receives notice of partial acquisition offer from the offeror

Easy Life Holdings Plans Partial Cash Acquisition Offer to Acquire 67.8086 Million Shares

Easy Life Holdings Shares to be Suspended from Trading on October 2, 2024

Easy Life Holdings Holds Board Meeting to Approve Conditional Rights Issue Financing Plan

Easy Life Holdings Executive Appointment Announcement

E-Living Holdings Clarifies the Use of Subscription Proceeds

Easylife Holdings Completes Subscription Matter, Issuing 226 Million New Shares with Net Proceeds of Approximately HKD 27.7 Million

VIRTUAL MIND released FY2024 H1 earnings on September 6, 2024 (BJT), with actual revenue of 29.93M HKD and EPS of -0.0508

VIRTUAL MIND released FY2023 Q1 earnings on September 6, 2024 (BJT), with revenue of 15.97M HKD and EPS of -0.0212

< 1B

1B - 5B

5B - 10B

10B - 50B

50B - 100B

100B - 500B

500B - 1T

≥ 1T

Market Value

Total Assets

< 100M

100M - 500M

500M - 1B

≥ 100B

Revenue

0 - 50M

50M - 100M

≥ 10B

Profits

< 0%

0% - 5%

5% - 10%

10 - 15%

15% - 20%

20 - 25%

25% - 30%

>= 30%

ROE(TTM)

= 0%

0% - 1%

1% - 3%

3% - 5%

5% - 8%

8% - 10%

>= 10%

Dividend Yield

0% - 10%

10% - 15%

20% - 30%

30% - 40%

40% - 50%

>= 50%

Net Profit Margin

0 - 0.05

0.05 - 0.1

0.1 - 0.2

0.2 - 0.4

0.4 - 0.6

0.6 - 0.8

0.8 - 1

>= 1

Asset Turnover

< 1.5

1.5 - 2

2 - 3

3 - 5

5 - 10

10 - 15

15 - 20

>= 20

Equity Multiplier

< 10%

10% - 30%

30% - 50%

50% - 70%

70 - 80%

80% - 90%

90% - 95%

>= 95%

Debt Ratio

CHK OIL

SHANDONG MOLONG

PETRO-KING

MIE HOLDINGS

D&G TECH

YUANHENG GAS

JX ENERGY

KINETIX SYSTEMS

YANCHANG PETRO

HAO WEN HLDGS

02910

00223

ELIFE HLDGS announced that it has met the resumption guidelines, including the release of unpublished financial results, conducting an independent investigation, assessing the impact on the company's business, and demonstrating compliance with listing rules. The company's shares will be suspended from trading starting December 2, 2024, and it has applied to resume trading on Monday (29th)

AASTOCKS

ELIFE HLDGS

ELIFE HLDGS has met the resumption guidelines and will resume trading on Monday

ELIFE HLDGS announced its interim results for the six months ended September, with revenue of HKD 60.93 million, a year-on-year decrease of 49%. It recorded a net profit of HKD 4.365 million, compared to a loss of HKD 69.94 million in the same period last year, turning from loss to profit; earnings per share were 0.03 HKD. No dividend was declared

"Performance" ELIFE HLDGS mid-term net profit of 4.37 million yuan from loss to profit

ELIFE HLDGS issued a profit warning, expecting a profit of approximately HKD 4.4 million for the six months ending in September, compared to a loss of HKD 69.9 million in the same period last year. The turnaround from loss to profit is mainly due to a recorded loss of approximately HKD 40.7 million from sales in the same period last year; and a net gain of approximately HKD 7.3 million from the reversal of expected credit loss provisions for trade and other receivables during this period

"Profit Alert" ELIFE HLDGS forecasts a turnaround, earning 4.4 million yuan in the first half of the year

ELIFE HLDGS announced its financial results for the fiscal year ending in March this year, with revenue recorded at HKD 178 million, a year-on-year decrease of 3.5%. The loss widened from HKD 32.01 million in the previous year to HKD 97.84 million, with a loss per share of 7.9 cents. No dividend was declared

"Performance" ELIFE HLDGS full-year loss expanded to 97.84 million yuan

ELIFE HLDGS announced its interim results for the six months ending September 2024, with revenue recorded at HKD 120 million, an increase of 178.8% year-on-year. Losses widened from HKD 4.5 million in the same period last year to HKD 69.94 million, with a loss per share of 6.2 cents. No dividend was declared

"Performance" ELIFE HLDGS 2024 mid-term loss expanded to 69.94 million

ELIFE HLDGS announced that the forensic investigation and internal control review have been completed, involving unusual trading allegations against former board members and issues related to missing documents. Independent investigators KPMG and FTI Consulting have submitted a report to the Stock Exchange. In response to the company's request, trading of its shares will be suspended from December 2, 2024, until further notice

ELIFE HLDGS: Forensic investigation and internal control review have been completed, trading suspension continues

01217

ELIFE HLDGS and CH INNOVATION jointly announced plans to submit a partial tender offer on May 14, 2025, to acquire 180 million tender shares, accounting for approximately 13.27% of the issued share capital. The offer price is HKD 0.056 per share, representing a discount of about 48.62% compared to the closing price of HKD 0.109 on the last trading day. If eligible shareholders accept the offer, a total payment of HKD 10.08 million will be required. The current offeror holds 226 million shares, accounting for approximately 16.66%

Zhitong

CH INNOVATION

ELIFE HLDGS plans to receive a partial acquisition offer from CH INNOVATION for approximately 48.62%

According to the Zhitong Finance APP, ELIFE HLDGS announced that it has appointed XinYong FangLue Risk Management Co., Ltd. as its internal control advisor, effective from April 25, 2025, to review the group's internal control systems and procedures, provide recommendations, and follow up on the remedial measures taken by the company

ELIFE HLDGS has appointed Shen Yongfang Risk Management as its internal control consultant

ELIFE HLDGS received a legal notice on April 15, 2025, in which the claimant accused the company of violating multiple representations and warranties in the agreement related to the fundraising transaction. The claimant is seeking compensation for damages and related costs, but the notice does not specify the amount claimed. The company's board of directors has not yet assessed the potential impact of the legal proceedings and is seeking legal advice to determine the implications, while reserving the right to counterclaims and other remedies

ELIFE HLDGS received a legal proceeding notice submitted by a claimant against the company

ELIFE HLDGS announced that starting from March 11, 2025, Tan Xin and Zhang Zhilin have been appointed as executive directors, while Lin Qiucheng, Wang Anxin, and Hu Guocai have been appointed as independent non-executive directors. At the same time, the previous directors have been dismissed. The company's shares will be suspended from trading starting December 2, 2024, until further notice

Finet HK

ELIFE HLDGS: Appointment of Directors and Changes in Board Composition, Suspension Continues

According to the announcement released by ELIFE HLDGS, Ms. Tan Xingxian (Ms. Tan) has resigned as the company secretary of the company and the authorized representative of the company under Rule 3.05 of the Securities Listing Rules of The Stock Exchange of Hong Kong Limited, effective from March 11, 2025

ELIFE HLDGS: Tan Xingxian resigns as company secretary

ELIFE HLDGS announced a change in its board of directors, effective March 5, 2025. Executive Directors Xiang Xin and Chen Xinqiong voluntarily suspended their positions, and Qiu Bin was appointed as the new Chairman and authorized representative under the listing rules, succeeding Xiang Xin. Other appointments include Cao Jiarong as Vice Chairman of the Nomination Committee, Chen Xiaodong as Executive Director and Co-Vice Chairman, Li Zongda as Non-Executive Director and Co-Vice Chairman, Zhou Deyin and Yang Qiong as Independent Non-Executive Directors, and Xiang Zhanwei and Zhang Jinhui as Co-Chief Executive Officers

ELIFE HLDGS: Qiu Bin has been appointed as chairman

ELIFE HLDGS announced that, starting from March 4, 2025, it will suspend the directorship and powers of non-executive director Guo Wei. The board of directors decided on this action due to Guo Wei's disregard for his responsibilities as a director, failure to ensure the accuracy of response documents, and lack of communication with the company's management since February 21, 2025

ELIFE HLDGS has suspended the directorship and powers of non-executive director Guo Wei

ELIFE HLDGS announced that five directors voluntarily suspended their positions, including non-executive directors Zhao Ruiqiang, Zhang Shaoyan, and independent non-executive directors Lin Quanzhi, Huang Zifeng, and Mei Yihe. Due to their decision being different from the majority opinion of the board, the board agreed to suspend their positions until further notice. The board stated that this move would not have a significant impact on the group's daily management, and the shares will continue to be suspended

ELIFE HLDGS: Five directors voluntarily suspend their positions and continue to be suspended from trading

ELIFE HLDGS received the resumption guidance from the Stock Exchange on January 15, 2025, which includes: publishing all unpublished financial results and addressing audit modifications; conducting an independent forensic investigation of the operating subsidiaries for the mid-2024 period; demonstrating that there are no doubts about the integrity and capability of the management; conducting an independent internal control review; complying with Listing Rule 13.24; and informing the market of all significant information to enable shareholders and investors to assess the company's condition

HKEX

ELIFE HLDGS received the resumption guidance from the Stock Exchange

ZHIDA TECH(02910.HK)

Valuation analysis

Institutional View & Shareholder

Analyst Ratings

ELIFE HLDGS has met the resumption guidelines and will resume trading on Monday

"Performance" ELIFE HLDGS mid-term net profit of 4.37 million yuan from loss to profit

"Profit Alert" ELIFE HLDGS forecasts a turnaround, earning 4.4 million yuan in the first half of the year

"Performance" ELIFE HLDGS full-year loss expanded to 97.84 million yuan

"Performance" ELIFE HLDGS 2024 mid-term loss expanded to 69.94 million